Antibiotic treatment administered to each patient for 14 days beginning at day 0 and microorganisms cultured in sputum samples at day 0 and day 14
| Patient no | Treatment | Microorganisms | |
|---|---|---|---|
| Day 0 | Day 14 | ||
| 1 | Cefotaxime/gentamicin | H influenzae | Insignificant commensals |
| 2 | Augmentin | P aeruginosa | P aeruginosa |
| 3 | Tazocin/tobramycin | H parainfluenzae | Insignificant commensals |
| 4 | Tazocin/gentamicin | P aeruginosa | P aeruginosa |
| 5 | Tazocin/tobramycin | P aeruginosa | No growth |
| 6 | Ceftazidime | H influenzae | Insignificant commensals |
| 7 | Ceftazidime/flucloxacillin | No growth | No growth |
| 8 | Ceftazidime/aztereonam | No growth | P aeruginosa |
| 9 | Ceftazidime | No growth | No growth |
| 10 | Cefotaxime | Insignificant commensals | H influenzae |
| 11 | Meropenem/gentamicin/nebulised colistin | P aeruginosa | No growth |
| 12 | Ceftazidime | P aeruginosa | No growth |
| 13 | Ceftazidime | No growth | No growth |
| 14 | Cefotaxime | H influenzae | Insignificant commensals |
| 15 | Ceftazidime/gentamicin | P aeruginosa | Insufficient sample |